Literature DB >> 188746

Pharmacological aftercare for homogeneous groups of patients.

B J Powell, E Othmer, C Sinkhorn.   

Abstract

In a study to evaluate the effectiveness of specific pharmacological treatment groups, former VA inpatients who have similar diagnoses and respond satisfatorily to drug treatment join a Prolixin group, a lithium group, or an affective disorder group. In monthly meetings patients learn about their illness, the importance of the taking medication as prescribed, and possible side-effects; they also receive psychological support. The 85 patients who joined the groups during the first 12 months attended 87.3 per cent of the sessions. Twenty per cent of them were rehospitalized, about half of them because they did not take medication as prescribed. The authors believe the groups are an economical and effective way to provide aftercare.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 188746     DOI: 10.1176/ps.28.2.125

Source DB:  PubMed          Journal:  Hosp Community Psychiatry        ISSN: 0022-1597


  5 in total

1.  Effectiveness of a specially trained pharmacist in a rural community mental health center.

Authors:  C E Rosen; W M Copp; S Holmes
Journal:  Public Health Rep       Date:  1978 Sep-Oct       Impact factor: 2.792

2.  Analysis of cost avoidance from pharmacy students' clinical interventions at a psychiatric hospital.

Authors:  Austin R Campbell; Leigh Anne Nelson; Ellie Elliott; Robin Hieber; Roger W Sommi
Journal:  Am J Pharm Educ       Date:  2011-02-10       Impact factor: 2.047

3.  Developing a comprehensive system for handling mental illness commitments.

Authors:  G C Sauer; S Kirk; C E George
Journal:  Psychiatr Q       Date:  1982

4.  Community mental health treatment: what works for whom?

Authors:  J Braff; M M Lefkowitz
Journal:  Psychiatr Q       Date:  1979

5.  Setting the stage: The initial immune response to blood-stage parasites.

Authors:  Allison N Bucşan; Kim C Williamson
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.